Month: December 2020 (Page 16)

After a long day of Zoom calls and worrying about pandemics, there’s nothing better than selecting some top-shelf cannabis flower, packing a bowl or twisting a J, lighting up and zoning out. Normally, for many, this would include turning on the TV and having your high interrupted by commercials andContinue Reading

Discover a collection of smartly dosed products from 3Chi including vapes, gummies, and sauces, containing 100% hemp-derived Delta 8 THC oil. The post Stay stress-free this holiday season with Delta-8 oil-infused goods appeared first on Leafly. Read More: Stay stress-free this holiday season with Delta-8 oil-infused goodsContinue Reading

With five states voting in favor of new marijuana markets last month, Metrc sees fresh opportunities to extend its dominance in the seed-to-sale tracking business by winning new government contracts. The Florida-based company also acknowledged its track record hasn’t been perfect – Metrc’s software has experienced occasional outages and slowdownsContinue Reading

Leafly speaks with key players for the Momentum business accelerator – a grant and resource program for underrepresented cannabis businesses. The post Eaze’s Momentum business accelerator invites applicants appeared first on Leafly. Read More: Eaze’s Momentum business accelerator invites applicantsContinue Reading

The uncertain regulatory environment in the hemp extract and CBD category is leading to an “explosion” of competitive crowding and consumer confusion, said Deanie Elsner, CEO of Charlotte’s Web, based in Denver, Colorado, at MJBizCon 2020 on Thursday as part of her talk on “Bringing CPG Marketing to Cannabis.” MJBizConContinue Reading

Shopping small this year? Check out these gifts for stoners that you can find on Etsy. The post Shop small with these 12 Etsy gifts for stoners appeared first on Leafly. Read More: Shop small with these 12 Etsy gifts for stonersContinue Reading

The U.S. Drug Enforcement Administration reiterated that a lawsuit challenging marijuana’s classification as a Schedule 1 drug under the federal Controlled Substances Act should be dismissed because of lack of jurisdiction and merit. The DEA’s assertion came in a 77-page response to a case in the 9th Circuit Court ofContinue Reading